Samsara BioCapital’s Instil Bio TIL Stock Holding History

Samsara BioCapital’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-89,414	Closed	-$985K	–	46
2023 Q2	$985K	Hold	89,414	–	–	0.17%	37
2023 Q1	$1.18M	Hold	89,414	–	–	0.24%	40
2022 Q4	$1.13M	Hold	89,414	–	–	0.24%	37
2022 Q3	$8.65M	Hold	89,414	–	–	2.02%	14
2022 Q2	$8.26M	Sell	89,414 -10,184	-10%	-$1.44M	2.2%	14
2022 Q1	$21.4M	Hold	99,598	–	–	5.39%	4
2021 Q4	$34.1M	Sell	99,598 -7,672	-7%	-$2.96M	6.61%	3
2021 Q3	$38.3M	Hold	107,270	–	–	6.02%	4
2021 Q2	$41.4M	Buy	107,270 +29,569	+38%	+$11M	5.12%	5
2021 Q1	$39M	Buy	+77,701	New	+$39.9M	7.19%	4

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Samsara BioCapital's TIL Position: Q3 2023 in Review

Samsara BioCapital sold out of Instil Bio (TIL) in Q3 2023, closing a stake of 89,414 shares — an estimated $985K sold.

Samsara BioCapital first reported a position in TIL in Q1 2021 and held it in 10 quarters. The position peaked at $41.4M in Q2 2021. 58 funds tracked by Wall St. Rank hold TIL as of Q3 2023.

Samsara BioCapital reported no remaining Instil Bio position as of Q3 2023 after selling out during the quarter.
Samsara BioCapital sold 89,414 Instil Bio shares in Q3 2023, an estimated $985K.
Samsara BioCapital first reported a position in Instil Bio in Q1 2021 and held it in 10 quarters.
Samsara BioCapital's Instil Bio position peaked at $41.4M in Q2 2021.
58 funds tracked by Wall St. Rank held Instil Bio as of Q3 2023.

Based on Samsara BioCapital's 13F filing for Q3 2023, filed 14 Nov 2023.